o, P SI, atho

7; a Dyslipidemia is an important complication of kidney showing that serum cholesterol levels have an independent influence on the graft and patient survival [6]. While development of chronic allograft nephropathy [7]. Better graft survival was reported in transplant patients on lipid lowering 2.1. Cell activation Human peripheral blood mononuclear cells (PBMC) were obtained from Available online at www.sciencedirect.com Transplant Immunology 18 (200transplantation, affecting almost 70 % of recipients [1]. Several studies have suggested that hyperlipidemia may play a role in chronic allograft nephropathy [2,3]. Dimény et al. have shown that pretransplant lipid levels correlated with posttransplant acute and chronic renal allograft rejection [4]. Ingulli et al